Dates and Times
End Date: 1/21/2014
ObjectivesAs a result of this educational activity, participants will be able to: RECOGNIZE the current limitations to lung cancer, DESCRIBE the current guidelines for lung cancer staging, DISTINGUISH the differences in therapy between adenocarcinoma or squamous carcinoma of the lung, DISCUSS the reasons and clinical rationale for molecular testing of lung cancers.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.